Literature DB >> 6150249

Somatostatin, a potent analgesic.

J Chrubasik, J Meynadier, S Blond, P Scherpereel, E Ackerman, M Weinstock, K Bonath, H Cramer, E Wünsch.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6150249     DOI： 10.1016/s0140-6736(84)92761-2

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  13 in total

1.  Tonic control of peripheral cutaneous nociceptors by somatostatin receptors.

Authors:  S M Carlton; J Du; S Zhou; R E Coggeshall
Journal:  J Neurosci       Date:  2001-06-01       Impact factor: 6.167

Review 2.  The epidural and intrathecal administration of somatotrophin-release inhibiting factor: native and synthetic analogues.

Authors:  D P Beltrutti; S Moessinger; G Varrassi
Journal:  Curr Rev Pain       Date:  2000

Review 3.  Patient-controlled spinal opiate analgesia in terminal cancer. Has its time really arrived?

Authors:  J Chrubasik; S Chrubasik; E Martin
Journal:  Drugs       Date:  1992-06       Impact factor: 9.546

4.  Commentary: octreotide and hypertrophic pulmonary osteoarthropathy.

Authors:  R T Penson; R M Rudd
Journal:  Thorax       Date:  1997-03       Impact factor: 9.139

5.  Effects of octreotide on responses to colorectal distension in the rat.

Authors:  X Su; M B Burton; G F Gebhart
Journal:  Gut       Date:  2001-05       Impact factor: 23.059

6.  Effects of Zusanli electroacupuncture on somatostatin expression in the rat brainstem.

Authors:  Qinghua Tian; Lihua Wang; Lifen Yao; Liming Zhang; Huixue Zhang
Journal:  J Mol Neurosci       Date:  2012-06-29       Impact factor: 3.444

7.  Inhibition of ASIC-Mediated Currents by Activation of Somatostatin 2 Receptors in Rat Dorsal Root Ganglion Neurons.

Authors:  Ting-Ting Liu; Shuang Wei; Ying Jin; Chun-Yu Qiu; Wang-Ping Hu
Journal:  Mol Neurobiol       Date:  2021-01-07       Impact factor: 5.590

8.  Treatment of resistant pain in hypertrophic pulmonary osteoarthropathy with subcutaneous octreotide.

Authors:  S A Johnson; P A Spiller; C M Faull
Journal:  Thorax       Date:  1997-03       Impact factor: 9.139

9.  [Pharmacotherapy of cancer pain : 2. Use of opioids.].

Authors:  N I Cherny; R K Portenoy; M Raber; M Zenz
Journal:  Schmerz       Date:  1995-01       Impact factor: 1.107

10.  Substance P-like immunoreactivity and somatostatin-like immunoreactivity in the ventricular fluid of patients with chronic pain syndromes.

Authors:  S Jost; C Reuner; J Geiger; M Mohadjer; E Milios; H Cramer
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1991       Impact factor: 5.270
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.